Viewing Study NCT06267560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-05-09 @ 1:43 PM
Study NCT ID: NCT06267560
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2024-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cardiovascular disease View
None Pelacarsen (TQJ230) View
None Elevated Lp(a) View